1.7mg semaglutide to tirzepatide Switching from Switching between weight-loss medications -

Another retrospective cohort study, which included 543,595 diabetic patients, found no increased risk of pancreatic cancer associated with GLP-1RA use compared to basal insulin over a 9-year follow-up period (Nagendra et al., 2023)

3) those with a family history of UCD or a family history of unexplained infant deaths (particularly males)

Epithalon research, while promising, remains more limited in scope and depth

CarelonRx is Anthems in-house PBM and tends to have stricter step therapy for newer GLP-1s

Stick to small, low-fat meals like toast, crackers, rice, or oatmeal, and steer clear of greasy or sugary foods

Let's explore what that switch could look like for you